73 per cent of pharmaceutical imports in the UK come from the EU. This equates to around 37 million packets of medicines every month from the EU worth £18.3 billion.
will turbo-charge these issues. NHS Providers has already warned that some #NHS trusts had seen shortages of up to 160 different drugs in the past six weeks as opposed to just 25 to 30 drugs in normal times.
drugs meant NHS concessionary spending on drugs was £315 million in 2017/18, compared to £46 million in the previous financial year.
updated since 2010 and pharma companies say 1,000 finished products and 700 ingredients would face tariffs when traded on WTO terms.
1. Finding UK drug manufacturing capacity is a challenge and
current production is limited. Insulin supply is a particular problem. Increasing capacity would take time to get UK approval for high-quality, safe
2. . #Stockpiling is an option but finding storage capacity is a challenge. There are simply not enough dedicated, sensitive UK facilities to do so given that temperature and humidity environments are crucial for medicine longevity.
3. Borrowing money to pay for the medicines. A 3 month stockpile costs £4.5bn. Which is a problem as pharmacies don’t get paid until the medicines